Chen Tien-Yu, Su Vincent Yi-Fong, Lee Chung-Hsin, Chung Chi-Hsiang, Tsai Chia-Kuang, Peng Chung-Kan, Lai Hsiao-Ching, Chien Wu-Chien, Tzeng Nian-Sheng
Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan.
Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei, 112, Taiwan.
Nat Sci Sleep. 2021 Sep 21;13:1631-1640. doi: 10.2147/NSS.S317746. eCollection 2021.
Asthma, which is caused by inflammation of the airways, affects the sensitivity of nerve endings. Narcolepsy is a chronic sleep disorder that may be caused by autoimmunity. Recent studies have reported a positive association between narcolepsy and asthma. We aimed to examine the association between asthma and narcolepsy and determine the effects of therapeutic corticosteroid or bronchodilator use.
We conducted a nationwide population-based, nested case-control study using Taiwan's National Health Insurance Research Database (NHIRD) between 2000 and 2013. Subjects with narcolepsy (ICD-9-CM code 347) were enrolled, with 1:3 estimated propensity score-matched controls based on sex, age, and index year. The association between narcolepsy and asthma was assessed using multiple logistic regression analyses. The covariates included sex, age, monthly insurance premiums, geographical area of residence, urbanization level of residence, level of care, and presence of diseases related to immune response and central nervous system. The effects of corticosteroid and bronchodilator use were also analyzed.
Overall, 2008 subjects were identified from the NHIRD (502 patients with narcolepsy and 1506 controls). The participants with narcolepsy had almost three times the level of previous asthma diagnosis than controls. Compared to those without asthma, patients with asthma had an adjusted odds ratio (OR) of 3.181 for narcolepsy comorbidity (95% confidence interval [CI]: 2.048-4.941, <0.001). The use of inhaled corticosteroids was associated with a lower risk of narcolepsy comorbidity, with an adjusted OR of 0.465 (95% CI, 0.250-0.634; <0.001), in patients with asthma when compared to those without treatment.
This study demonstrated a significantly higher level of previous asthma diagnosis in patients with narcolepsy. The use of inhaled corticosteroids was associated with a lower risk of narcolepsy comorbidity in asthma patients, compared to those without treatment.
哮喘由气道炎症引起,会影响神经末梢的敏感性。发作性睡病是一种慢性睡眠障碍,可能由自身免疫引起。最近的研究报告了发作性睡病与哮喘之间存在正相关。我们旨在研究哮喘与发作性睡病之间的关联,并确定治疗性使用皮质类固醇或支气管扩张剂的效果。
我们利用2000年至2013年台湾地区国民健康保险研究数据库(NHIRD)进行了一项基于全国人口的巢式病例对照研究。纳入发作性睡病患者(国际疾病分类第九版临床修订本代码347),并根据性别、年龄和索引年份按1:3的估计倾向评分匹配对照。使用多重逻辑回归分析评估发作性睡病与哮喘之间的关联。协变量包括性别、年龄、每月保险费、居住地理区域、居住城市化水平、护理水平以及与免疫反应和中枢神经系统相关疾病的存在情况。还分析了皮质类固醇和支气管扩张剂使用的效果。
总体而言,从NHIRD中识别出2008名受试者(502例发作性睡病患者和1506名对照)。发作性睡病患者先前哮喘诊断水平几乎是对照的三倍。与无哮喘者相比,哮喘患者并发发作性睡病的调整优势比(OR)为3.181(95%置信区间[CI]:2.048 - 4.941,<0.001)。与未接受治疗的哮喘患者相比,使用吸入性皮质类固醇与并发发作性睡病的风险较低相关,调整后的OR为0.465(95%CI,0.250 - 0.634;<0.001)。
本研究表明发作性睡病患者先前哮喘诊断水平显著更高。与未接受治疗的患者相比,哮喘患者使用吸入性皮质类固醇与并发发作性睡病的风险较低相关。